What does this research mean for the field?

Rezafungin is clinically successful in treating invasive candidiasis resulting from esophagogastric anastomotic leaks. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Investigate the efficacy of rezafungin in treating invasive candidiasis due to esophagogastric anastomotic leaks.

March 13, 2026Open Access

Rezafungin for the treatment of invasive candidiasis secondary to esophagogastric anastomotic leak: clinical success in a complex situation

Key Points

Investigate the efficacy of rezafungin in treating invasive candidiasis due to esophagogastric anastomotic leaks.
Clinical evaluation of patients with invasive candidiasis
Administration of rezafungin as an antifungal treatment
Assessment of clinical outcomes post-treatment
Notable improvement in clinical presentations
Reduction in infection-related complications
Successful treatment outcomes in complex cases

Abstract

Revista Española de Quimioterapia tiene un carácter multidisciplinar y está dirigida a todos aquellos profesionales involucrados en la epidemiología, diagnóstico, clínica y tratamiento de las enfermedades infecciosas. Fundada en 1988 por la Sociedad Española de Quimioterapia.

Read Full Paperexternally

Demander à l'IA

Bookmark

View Full Paper